MARC WILSON: Open Payments
NPI 1508443771 · BENBROOK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$364 in 17 payments from 12 companies in 2025. Trend: 2023 $717 · 2024 $776 · 2025 $364
Food & beverage: $364
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $77 |
| Lilly USA, LLC | 3 | $62 |
| Novo Nordisk Inc | 2 | $34 |
| Sumitomo Pharma America, Inc. | 1 | $28 |
| KYOWA KIRIN, INC. | 1 | $28 |
| GlaxoSmithKline, LLC. | 1 | $26 |
| Amgen Inc. | 1 | $21 |
| Gilead Sciences, Inc. | 1 | $21 |
| Seqirus USA Inc | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
Products named: JARDIANCE, Rybelsus, GEMTESA, CRYSVITA, TRELEGY ELLIPTA, MOUNJARO, EVENITY, Fluad.
Industry payments across TX — which companies pay providers there.
